NCT04614428

Brief Summary

Despite a range of evidence-based programs to identify high-risk patients and apply strategies to keep them out of hospital, a growing number of cases are "resistant" to such programs. These "seasonal frequent flyers" routinely overwhelm hospital services. The investigators have identified vulnerability to provocation of seasonal and acute weather changes ("seasonality") as a major driver of preventable/costly hospitalisations in typically older patients with heart disease and multimorbidity subject to gold-standard care. From this research the investigators developed the RESILIENCE Program which is tailored to each person and designed to assist the participants to become more "resilient" to changes in the weather. The overall aim of the RESILIENCE Trial is to demonstrate the cost-effectiveness of an individually tailored, interventional health care program designed to address the debilitating, costly and deadly phenomenon of seasonal vulnerability in a growing number of individuals admitted to hospital with chronic heart disease and multimorbidity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
203

participants targeted

Target at P50-P75 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 4, 2020

Completed
21 days until next milestone

Study Start

First participant enrolled

November 25, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2023

Completed
Last Updated

March 27, 2024

Status Verified

March 1, 2024

Enrollment Period

2.7 years

First QC Date

October 29, 2020

Last Update Submit

March 25, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Days-alive-out-of-hospital (DAOH)

    Defined as the proportion of maximal days follow-up where the study participant was not admitted to hospital and alive. DAOH data will be collected from hospital records. During minimum 12-month follow-up, the pre-specified threshold for a clinically significant effect in favour of the RESILIENCE Program is a 10% increase in DOAH compared to "standard care".

    12-months (minimum) post randomisation to study census (July 2023)

Secondary Outcomes (3)

  • Overall pattern of hospitalization

    12-months (minimum) post randomisation to study census

  • Number of community care visits

    12-months (minimum) post randomisation to study census

  • Healthcare costs

    12-months (minimum) post randomisation to study census

Study Arms (2)

Standard Care Group

NO INTERVENTION

Participants will receive the standard care provided by their institution.

RESILIENCE Program group

ACTIVE COMPARATOR

Participants will receive the RESILIENCE Program on top of the standard care provided by their institution.

Behavioral: RESILIENCE Program

Interventions

In addition to the standard care participants would normally receive (including exposure to any standard hospital avoidance programs), the 150 participants assigned to the RESILIENCE Program group will receive a combination of strategies designed to promote seasonal resilience. This includes profiling of seasonal vulnerability; a 60-80 minute home visit by the RESILIENCE Nurse to assess physiological status, behavioural adaptations, environment, and modulating factors; a dedicated RESILIENCE Clinic with a dedicated RESILIENCE physician to develop a long-term plan to help promote/maintain seasonal resilience and; a structured follow-up over the next 12 months to monitor and adjust the participant's status and management from a seasonal perspective.

RESILIENCE Program group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individual aged 18 years and over.
  • Admitted to hospital due to a medical emergency for any reason but with a chronic form of heart disease (i.e. including. coronary artery disease, atrial fibrillation and/or heart failure) requiring treatment
  • Multimorbidity (defined as two or more chronic conditions requiring active treatment/management).
  • A planned discharge to home within a 10km radius of the hospital.

You may not qualify if:

  • Living in residential aged care
  • Terminal illness and/or unable to give informed consent
  • Died during index admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Austin Health

Heidelberg, Victoria, 3084, Australia

Location

Related Publications (2)

  • Stewart S, Patel SK, Lancefield TF, Sampaio Rodrigues T, Doumtsis N, Moini N, Harley A, Vaughan-Fowler ER, Chan YK, Chen A, Chye D, Liew DF, McMaster C, Ramchand J, Yates PA, Kwong JC, McDonald CF, Burrell LM. Promoting resilience to weather-related and seasonal provocations to health in people with multimorbid heart disease: a prospective pragmatic, randomised trial. Med J Aust. 2025 Jul 21;223(2):77-84. doi: 10.5694/mja2.52699. Epub 2025 Jun 24.

  • Stewart S, Patel SK, Lancefield TF, Rodrigues TS, Doumtsis N, Jess A, Vaughan-Fowler ER, Chan YK, Ramchand J, Yates PA, Kwong JC, McDonald CF, Burrell LM. Vulnerability to environmental and climatic health provocations among women and men hospitalized with chronic heart disease: insights from the RESILIENCE TRIAL cohort. Eur J Cardiovasc Nurs. 2024 Apr 12;23(3):278-286. doi: 10.1093/eurjcn/zvad076.

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Louise M Burrell, MD

    University of Melbourne

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The people assessing the outcomes will be masked
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomised control trial of two parallel groups; 1. Standard Care 2. Standard Care + RESILIENCE Program
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Senior Research Fellow

Study Record Dates

First Submitted

October 29, 2020

First Posted

November 4, 2020

Study Start

November 25, 2020

Primary Completion

July 28, 2023

Study Completion

July 28, 2023

Last Updated

March 27, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Trial data will be disseminated in the form of a publication to a relevant clinical journal and presentation at appropriate scientific conferences. Individual participant data that underlie the published results, may be shared on request by the RESILIENCE TRIAL Investigators at the completion of the trial and reporting of the endpoints.

Shared Documents
STUDY PROTOCOL
Time Frame
Beginning following main results publication; no end date determined
Access Criteria
Case-by-case basis at the discretion of the Primary Sponsor and RESILIENCE TRIAL Investigators and provide a methodologically sound proposal.

Locations